Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) kicked off on Tuesday, up 7.16% from the previous trading day, before settling in for the closing price of $4.19. Over the past 52 weeks, IRWD has traded in a range of $3.79-$15.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 5.56% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 103.33%. With a float of $155.59 million, this company’s outstanding shares have now reached $156.35 million.
In an organization with 267 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 99.49%, operating margin of 30.69%, and the pretax margin is 21.5%.
Ironwood Pharmaceuticals Inc (IRWD) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Ironwood Pharmaceuticals Inc is 2.60%, while institutional ownership is 108.20%. The most recent insider transaction that took place on Aug 12 ’24, was worth 42,316. In this transaction Chief Legal Officer of this company sold 9,910 shares at a rate of $4.27, taking the stock ownership to the 284,661 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Principal Accounting Officer sold 3,107 for $4.27, making the entire transaction worth $13,267. This insider now owns 158,370 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported 0.09 earnings per share (EPS), lower than consensus estimate (set at 0.16) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 103.33% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Take a look at Ironwood Pharmaceuticals Inc’s (IRWD) current performance indicators. Last quarter, stock had a quick ratio of 3.92. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.79. Likewise, its price to free cash flow for the trailing twelve months is 4.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.04, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.36 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Let’s dig in a bit further. During the last 5-days, its volume was 1.37 million. That was inferior than the volume of 2.96 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 74.54%. Additionally, its Average True Range was 0.26.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 21.12%, which indicates a significant decrease from 88.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.97% in the past 14 days, which was lower than the 86.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.32, while its 200-day Moving Average is $7.33. However, in the short run, Ironwood Pharmaceuticals Inc’s stock first resistance to watch stands at $4.65. Second resistance stands at $4.80. The third major resistance level sits at $5.10. If the price goes on to break the first support level at $4.20, it is likely to go to the next support level at $3.90. Assuming the price breaks the second support level, the third support level stands at $3.75.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
The company with the Market Capitalisation of 717.23 million has total of 159,739K Shares Outstanding. Its annual sales at the moment are 442,740 K in contrast with the sum of -1,002 M annual income. Company’s last quarter sales were recorded 94,400 K and last quarter income was -860 K.
